11Aug
COVID Impact as a Standalone Indemnity in M&A Transactions
Introduction - The COVID virus has ushered in unprecedented and challenging times for our country and the global community. From the deeply personal pain and suffering caused by the virus as a health pandemic to behavioral adjustments in the consumer population at large (“social distancing,” etc.), to every day, but very real, burdens created by business closures and shelter in place orders, the full force and impact of the virus on our society won’t be known for a long time....
By:
Goulston & Storrs PC
Related
In today’s world, hospitals have to be prepared for anything and everything, and not just medical e...
Read More >
In Allen v. Ambu-Stat, LLC, No. 18-10640 (January 16, 2020), the U.S. Court of Appeals for the Eleve...
Read More >
On 9 January 2020 the Federal Trade Commission (FTC) held a public workshop in Washington, D.C. to a...
Read More >
M&A professionals greeted 2019 with a note of caution. Following a strong year for M&A in 2018, opti...
Read More >
The Small Business Administration (SBA) today issued a significant final rule addressing numerous is...
Read More >
In times of uncertainty and disruption, setting expectations for performance with business partners ...
Read More >